Aperture Health, Inc. Announces the Formation of a Joint Venture with Reliable Medical to Market and Expand Services to the Infusion Therapy Market
FAIRFIELD, N.J., Jan. 27, 2012 /PRNewswire/ — Aperture Health, Inc. (OTC: APRE) announced that it has executed a Memorandum of Understanding that provides for the formation of a Joint Venture between Aperture Health, through its’ wholly owned subsidiary Triad Therapeutics and Reliable Medical the basis of which shall be to market and provide home care services to the infusion therapy market. Reliable Medical is a Joint Commission accredited, private NJ home respiratory/durable medical equipment service provider that has been operating for over 8 years. Reliable is a recognized leader in the home care market throughout the central and northern NJ areas. Reliable’s reputation for superior customer service and product fulfillment capabilities has resulted in its acknowledgment as a preferred provider of home care services to patient clients referred from hospital discharge planners and physicians’ offices.
The Joint Venture combines Triad’s expertise in marketing and provision of home IV therapy services with the well established and respected sales and service professionals at Reliable. Aperture anticipates significant additional home IV market penetration and subsequent revenue generation for 2012 and beyond. As part of the Joint Venture with Reliable, Aperture has allocated equity compensation consideration coupled to revenue milestones up to and in excess of $2,000,000.00.
James Hennig, R.Ph, Chief Executive Officer and Chairman of the Board of Directors commented, “We are very pleased to have partnered with Reliable Medical allowing Aperture to leverage its home care IV capability to accelerate revenues for its wholly owned subsidiary Triad Therapeutics and in turn enhance Reliable’s scope of services and increased market presence. We believe the combination of both companies attributes will increase Aperture’s market penetration and produce accretive financial results. “
About Aperture Health, and Triad Therapeutics
Aperture Health through its wholly owned subsidiary Triad Therapeutics operates a fully JCAHO accredited home IV therapy company, achieving this “gold standard” status in 2007. The company has built a well respected reputation in its industry for its therapy expertise and commitment to care for its patient clients. The company services clients throughout the States of New Jersey, New York and Connecticut, providing opportunity for organic growth. Triad’s full time marketing and sales personnel continuously represent the company in the core services areas, growing and maintaining the company’s referral source base. Patient referrals are made from physicians, hospitals, insurance companies, veterinarians and hospice care providers that have established a professional rapport with Triad
Certain statements in this news release are forward-looking, including (without limitation) growing revenues and earnings, expected results from current projects and attracting new business. Undue reliance should not be placed on such forward-looking statements because the matters they describe are subject to known and unknown risks, uncertainties and other unpredictable factors, many of which are beyond the Company’s control. The Company’s actual results, performance and trends could differ materially from those indicated or implied by such statements as a result of various factors, including (without limitation) the continued strengthening of Triad’s selling and marketing functions, continued customer satisfaction, contract renewal, new product development, continued availability of capable dedicated personnel, continued cost management, success and availability of acquisitions, availability of financing and other factors, as well as by factors applicable to most companies such as general economic, competitive and other business and civil conditions. Information regarding certain of those and other risk factors and cautionary statements that could affect future results, performance or trends is discussed in the Company’s OTC Disclosure Statement and unaudited management financials posted on www.pinksheets.com . All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date hereof.
SOURCE Aperture Health, Inc.